← Open Payments lookup

SEAN FENG: Open Payments

NPI 1417427535 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$374 in 14 payments from 13 companies in 2025. Trend: 2023 $628 · 2024 $597 · 2025 $374

Food & beverage: $374
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$67
Alnylam Pharmaceuticals Inc.1$36
Agios Pharmaceuticals, Inc.1$32
SpringWorks Therapeutics, Inc.1$31
GlaxoSmithKline, LLC.1$31
Genentech USA, Inc.1$29
Rigel Pharmaceuticals, Inc.1$27
BeOne Medicines USA, Inc.1$23
ABBVIE INC.1$23
Genmab U.S., Inc.1$21

Products named: LYNPARZA, GIVLAARI, PYRUKYND, GOMEKLI, BLENREP, Polivy, TAVALISSE, BRUKINSA.

Industry payments across MA — which companies pay providers there.